Clinical Trial

A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size

Study acronym: EndoAIM
Recruiting
View on ClinicalTrials.gov →
Summary
Colorectal polyp size is related to the risk of exhibiting advanced histological features. Moreover, polyps larger than 10 mm are associated with an elevated risk of metachronous advanced neoplasia and colorectal cancer (CRC). Consequently, accurate measurement of polyp size, especially at the 10 mm threshold is critical for risk stratification and surveillance intervals. Furthermore, polyp size is also important for the choice of the appropriate resection procedures. Underestimation may lead to delayed diagnosis, thereby increasing the risk of colorectal cancer, while overestimation may result in unnecessary surveillance endoscopies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-25.
Status change: Not Yet Recruiting → Recruiting 2026-04-20
Trial Details
NCT Number NCT06957015
Lead Sponsor Chinese University of Hong Kong
Conditions Colonic Polyps, CRC (Colorectal Cancer), Artificial Intelligence (AI)
Enrollment 278 participants
Start Date 2025-05-13
Primary Completion 2027-05-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-23